Aeglea BioTherapeutics
Stock Forecast, Prediction & Price Target
Aeglea BioTherapeutics Financial Estimates
Aeglea BioTherapeutics Revenue Estimates
Aeglea BioTherapeutics EBITDA Estimates
Aeglea BioTherapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $18.73M 0% | $2.32M -87.57% | Avg: $9.31M Low: $14.43M High: $4.19M avg. 300% | |||
Net Income
% change YoY
| $-80.3M N/A | $-65.80M 18.05% | $-83.81M -27.37% | Avg: $-63.21M Low: $-106.63M High: $-19.80M avg. 24.58% | |||
EBITDA
% change YoY
| $-80.48M N/A | $-65.64M 18.43% | $-84.78M -29.14% | Avg: $-1.86M Low: $-2.88M High: $-839.55K avg. 97.80% | |||
EPS
% change YoY
| -$37.61 N/A | -$25.02 33.47% | -$24.86 0.63% | Avg: -$0.75 Low: -$1.27 High: -$0.23 avg. 96.98% | |||
Operating Expenses
% change YoY
| $81.48M N/A | $84.38M 3.56% | $87.11M 3.22% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Aeglea BioTherapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 24.58% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -106.63M, average is -63.21M and high is -19.80M.
What is Aeglea BioTherapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 300% in 2025-2025.
We have gathered data from N/A analysts. Their low revenue estimate is $14.43M, average is $9.31M and high is $4.19M.
What is Aeglea BioTherapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 96.98% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.27, average is -$0.75 and high is $-0.23.